Schwartz, G. G., Steg, P. G., Szarek, M., Bittner, V. A., Diaz, R., Goodman, S. G., . . . Bhatt, D. L. (2020). Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial. Circulation.
Chicago Style CitationSchwartz, Gregory G., et al. "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification By Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial." Circulation 2020.
Cita MLASchwartz, Gregory G., et al. "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification By Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial." Circulation 2020.